Vimta Labs Q1 Results
- BSE: 524394
- NSE: VIMTALABS
- ISIN: INE579C01029
- Sector: Biotechnology & Drugs
BSE
465.45
-22.70 (-4.65%)
-22.70 (-4.65%)Volume9.08 K
Updated: Fri 13 Feb, 2026 | 15:29:26
NSE
463-27.70 (-5.64%)
-27.70 (-5.64%)Volume2.15 L
Updated: Fri 13 Feb, 2026 | 15:25:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Vimta Labs Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 73.74 | 70.62 | 4.42% | 56.93 | 29.52% |
| Depreciation/ Amortization | 9.86 | 9.21 | 7.06% | 7.98 | 23.55% |
| Operating Income | 23.83 | 23.83 | 0.01% | 17.95 | 32.77% |
| Net Income | 18.89 | 18.32 | 3.14% | 12.28 | 53.85% |
| Other Operating Expenses Total | 17.25 | 12.78 | 34.93% | 12.21 | 41.26% |
| Net Income Before Taxes | 25.26 | 25.03 | 0.94% | 18.17 | 39.06% |
| Total Revenue | 97.56 | 94.44 | 3.31% | 74.88 | 30.30% |
| Selling/ General/ Admin Expenses Total | 27.82 | 30.45 | -8.63% | 22.45 | 23.93% |
| Diluted Normalized EPS | 4.21 | 4.03 | 4.40% | 3.08 | 36.49% |